Mo1913 – Two Year Experience with Vedolizumab in Inflammatory Bowel Disease Patients: Results of the Icc Case Series, a Nationwide Prospective Observational Cohort Study
2019 ◽
Vol 13
(Supplement_1)
◽
pp. S363-S364
◽
2016 ◽
Vol 10
(11)
◽
pp. 1287-1293
◽
2018 ◽
Vol 12
(supplement_1)
◽
pp. S373-S374
◽
2018 ◽
Vol 12
(supplement_1)
◽
pp. S353-S353